Top View
- A Review of the Biological and Clinical Implications of RAS-MAPK Pathway Alterations in Neuroblastoma
- MEK1/2 Dual-Specificity Protein Kinases
- Phosphorylation-Dependent Mechanism in a T-Cell Line (T Lymphocyte/Signal Transduction/Phosphatase) BRUCE C
- Relevant Melanoma Findings Relevant Biomarkers
- Langerhans Cell Histiocytosis Associated with Lymphoma: an Incidental Finding That Is Not Associated with BRAF Or MAP2K1 Mutatio
- Novel Multitarget Therapies for Lung Cancer and Respiratory Disease
- A Role for Raf Kinase Inhibitory Protein in Spindle Checkpoint Regulation Marsha Rich Rosner*
- Bioinformatics Approaches to Cancer Biomarker Discovery
- The Roles of ERK1 and ERK2 MAP Kinase in Neural Development and Disease
- Senescence of Human Fibroblasts Induced by Oncogenic Raf
- The 14-3-3 Proteins As Important Allosteric Regulators of Protein Kinases
- C-Raf (Y340D; Y341D) [GST-Tagged] Kinase
- MEK1 Mediates a Positive Feedback on Raf-1 Activity Independently of Ras and Src
- Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
- The Mechanism of Activation of Monomeric B-Raf V600E
- Protein Phosphatases 1 and 2A Promote Raf-1 Activation by Regulating 14-3-3 Interactions
- ERK/MAPK-Independent Functions of Raf Kinases 1577 1993) and the Substrate MEK (Dhillon Et Al., 2002)
- Activated Raf Kinase Inhibits Muscle Cell Differentiation Through a MEF2- Dependent Mechanism
- Inhibition of Oncogenic Kinases: an in Vitro Validated Computational Approach Identified Potential Multi- Target Anticancer Compounds
- RAS Symposium Program 2021
- Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course
- Mutations of C-RAF Are Rare in Human Cancer Because C-RAF Has a Low Basal Kinase Activity Compared with B-RAF
- Mutations of the BRAF Gene in Squamous Cell Carcinoma of the Head and Neck
- Discovering Novel Feedback and Crosstalk Mechanisms in Cellular Signaling Pathways
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/Mtor Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
- LY3009120, a Pan-Raf Kinase Inhibitor, Inhibits Adipogenesis Of
- A New Regulatory Mechanism for Raf Kinase Activation, Retinoic Acid- Bound Crabp1 Received: 9 November 2018 Sung Wook Park1, Jennifer Nhieu1, Shawna D
- B-Raf and the Inhibitors: from Bench to Bedside Tiangui Huang1, Michael Karsy1,2, Jian Zhuge1, Minghao Zhong1 and Delong Liu3*
- Mtor and Jak/STAT Pathways for Effective Leukemia Therapy
- Cot Protooncoprotein Activates the Dual Specificity Kinases MEK-1 and SEK-1 and Induces Di€Erentiation of PC12 Cells
- New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome Leah J
- Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
- Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future